Cargando…

STAT3, a Master Regulator of Anti-Tumor Immune Response

Immune cells in the tumor microenvironment regulate cancer growth. Thus cancer progression is dependent on the activation or repression of transcription programs involved in the proliferation/activation of lymphoid and myeloid cells. One of the main transcription factors involved in many of these pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Rébé, Cédric, Ghiringhelli, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770459/
https://www.ncbi.nlm.nih.gov/pubmed/31480382
http://dx.doi.org/10.3390/cancers11091280
_version_ 1783455477964734464
author Rébé, Cédric
Ghiringhelli, François
author_facet Rébé, Cédric
Ghiringhelli, François
author_sort Rébé, Cédric
collection PubMed
description Immune cells in the tumor microenvironment regulate cancer growth. Thus cancer progression is dependent on the activation or repression of transcription programs involved in the proliferation/activation of lymphoid and myeloid cells. One of the main transcription factors involved in many of these pathways is the signal transducer and activator of transcription 3 (STAT3). In this review we will focus on the role of STAT3 and its regulation, e.g., by phosphorylation or acetylation in immune cells and how it might impact immune cell function and tumor progression. Moreover, we will review the ability of STAT3 to regulate checkpoint inhibitors.
format Online
Article
Text
id pubmed-6770459
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-67704592019-10-30 STAT3, a Master Regulator of Anti-Tumor Immune Response Rébé, Cédric Ghiringhelli, François Cancers (Basel) Review Immune cells in the tumor microenvironment regulate cancer growth. Thus cancer progression is dependent on the activation or repression of transcription programs involved in the proliferation/activation of lymphoid and myeloid cells. One of the main transcription factors involved in many of these pathways is the signal transducer and activator of transcription 3 (STAT3). In this review we will focus on the role of STAT3 and its regulation, e.g., by phosphorylation or acetylation in immune cells and how it might impact immune cell function and tumor progression. Moreover, we will review the ability of STAT3 to regulate checkpoint inhibitors. MDPI 2019-08-30 /pmc/articles/PMC6770459/ /pubmed/31480382 http://dx.doi.org/10.3390/cancers11091280 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Rébé, Cédric
Ghiringhelli, François
STAT3, a Master Regulator of Anti-Tumor Immune Response
title STAT3, a Master Regulator of Anti-Tumor Immune Response
title_full STAT3, a Master Regulator of Anti-Tumor Immune Response
title_fullStr STAT3, a Master Regulator of Anti-Tumor Immune Response
title_full_unstemmed STAT3, a Master Regulator of Anti-Tumor Immune Response
title_short STAT3, a Master Regulator of Anti-Tumor Immune Response
title_sort stat3, a master regulator of anti-tumor immune response
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770459/
https://www.ncbi.nlm.nih.gov/pubmed/31480382
http://dx.doi.org/10.3390/cancers11091280
work_keys_str_mv AT rebecedric stat3amasterregulatorofantitumorimmuneresponse
AT ghiringhellifrancois stat3amasterregulatorofantitumorimmuneresponse